- Research works
- 5 ▲ 1145% vs 2013–17
- Citations
- 35 7.0 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 74% world 28%
Not ranked overall: Clinipace (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Clinipace (United States) publish most on?
By volume in 2022–2025: Long-Term Effects of COVID-19, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research and Pharmaceutical industry and healthcare.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Long-Term Effects of COVID-19 Neurology 0 works
- 2 COVID-19 Clinical Research Studies Infectious Diseases 0 works
- 3 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 4 Pharmaceutical industry and healthcare Pharmacology 0 works
- 5 Health and Medical Research Impacts Public Health, Environmental and Occupational Health 0 works
- 6 Biomedical Ethics and Regulation Physiology 0 works
- 7 Poxvirus research and outbreaks Virology 0 works
- 8 Virus-based gene therapy research Genetics 0 works
- 9 Herpesvirus Infections and Treatments Epidemiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Clinipace (United States)'s research output changed?
Output in 2018–2022 was 1145% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Morrisville
- North Carolina Institute of Medicine
- American Society of Echocardiography
- Metabolon (United States)
- Worldwide Clinical Trials (United States)
- Q2 Solutions (United States)
- Protochips (United States)
- Liquidia Technologies (United States)
- HexaTech (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.